These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine. Hohnloser SH, van de Loo A, Baedeker F. J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608 [Abstract] [Full Text] [Related]
9. Short QT syndrome. Brugada R, Hong K, Cordeiro JM, Dumaine R. CMAJ; 2005 Nov 22; 173(11):1349-54. PubMed ID: 16301704 [Abstract] [Full Text] [Related]
10. The short QT syndrome. Cross B, Homoud M, Link M, Foote C, Garlitski AC, Weinstock J, Estes NA. J Interv Card Electrophysiol; 2011 Jun 22; 31(1):25-31. PubMed ID: 21491125 [No Abstract] [Full Text] [Related]
11. Short QT-a silent harbinger of lethal arrhythmias. Majumder B, Kumar A. Indian Heart J; 2008 Jun 22; 60(6):584-7. PubMed ID: 19276501 [No Abstract] [Full Text] [Related]
12. Sudden death due to cardiac arrhythmias. Huikuri HV, Castellanos A, Myerburg RJ. N Engl J Med; 2001 Nov 15; 345(20):1473-82. PubMed ID: 11794197 [No Abstract] [Full Text] [Related]
17. Disopyramide: although potentially life-threatening in the setting of long QT, could it be life-saving in short QT syndrome? Dumaine R, Antzelevitch C. J Mol Cell Cardiol; 2006 Sep 15; 41(3):421-3. PubMed ID: 16863649 [No Abstract] [Full Text] [Related]
18. Short QT syndrome review. Van Houzen NE, Alsheikh-Ali AA, Garlitski AC, Homoud MK, Weinstock J, Link MS, Estes NA. J Interv Card Electrophysiol; 2008 Oct 15; 23(1):1-5. PubMed ID: 18299973 [No Abstract] [Full Text] [Related]